InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Taich Adam. Insider active across 2 companies, notably 10x Genomics, Inc.. Cumulatively, 10 disclosures have been published. Breakdown: 0 buy · 7 sells. Total volume traded: €1.9m. History available since 2 March 2023. The latest transaction was disclosed on 24 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Taich Adam is Chief Financial Officer at 10x Genomics, Inc. and Interim CEO at SomaLogic, Inc. Across 9 filings in total, the 9 sampled filings, from 2023-10-02 to 2026-05-27, report only sales for a total of EUR 952626, with 10x Genomics, Inc. as the most frequently mentioned company.